Pharmaceuticals, Biotechnology and Life Sciences
Horizon Pharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number entitled “Treatment of Pain with Topical Diclofenac” for a drug Pennsaid 2% w/w.
The estimated number of adolescents dying of AIDS in the Asia Pacific region has more than doubled since 2005, experts said on Monday, warning of a “hidden epidemic”.
UNICEF urged Asian countries to improve teenagers’ access to testing, saying many young people do not know their HIV status because of parental consent requirements for tests.
AHF Marks World AIDS Day with HIV Testing & Awareness Events in 32 Countries; Celebrates Milestone: 500,000 Lives in Care
Celyad advances first NKG2D CAR T-Cell Phase I study
Biophytis has appointed Pierre J. Dilda, PhD, as Director of
Research.
Neovacs, a France-based specialist in active immunotherapies for the treatment of autoimmune diseases, has decided to engage in the field of immuno-oncology after a recommendations by its Scientific Adivsory Board
Funding for tuberculosis research fell $1.3 billion short of global targets last year, threatening worldwide goals to eliminate the disease between 2030 and 2035, researchers said on Monday.
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Low levels of breast cancer factor 1 (BRCA1) protein in the brain may contribute to dementia, according to results of a National Institutes of Health (NIH)-funded study, published in Nature Communications.
Janssen Biotech, Inc. and Janssen-Cilag International NV (Janssen) are seeking approval from the U.S. and European authorities for Chron’s disease drug Stelara.